Nan Shan Life Insurance Co., Ltd. Gilead Sciences, Inc. Transaction History
Nan Shan Life Insurance Co., Ltd.
- $4.22 Billion
- Q3 2024
A detailed history of Nan Shan Life Insurance Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nan Shan Life Insurance Co., Ltd. holds 736,382 shares of GILD stock, worth $66.4 Million. This represents 1.46% of its overall portfolio holdings.
Number of Shares
736,382
Previous 640,350
15.0%
Holding current value
$66.4 Million
Previous $43.9 Million
40.49%
% of portfolio
1.46%
Previous 1.04%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
1,923Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.9 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.57 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.43 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...